Importantly, changes in bacteria that are known to influence chemerin-associated diseases were differentially present between facilities, highlighting that the microbiome might be a confounding factor when studying the role of chemerin signaling in obesity and inflammation in vivo. Here, RARRES2 is linked to Obesity.